Evidence map›Paper›PMID 34062183›Full record

ArticleThe Journal of infection2021

Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.

Laura Pezzati, Andrea Giacomelli, Davide Mileto, Federico Conti, Gloria Gagliardi, Alberto Rizzo, Laura Milazzo, Marco Schiuma, Alice Covizzi, Matteo Siano and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Laura PezzatiInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy. Electronic address: laura.pezzati@unimi.it.
Andrea GiacomelliInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy.
Davide MiletoLaboratory of Clinical Microbiology, Virology and Bioemergencies Diagnostics, ASST Fatebenefratelli-Sacco, Milan, Italy.
Federico ContiInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Gloria GagliardiLaboratory of Clinical Microbiology, Virology and Bioemergencies Diagnostics, ASST Fatebenefratelli-Sacco, Milan, Italy.
Alberto RizzoLaboratory of Clinical Microbiology, Virology and Bioemergencies Diagnostics, ASST Fatebenefratelli-Sacco, Milan, Italy.
Laura MilazzoInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy.
Marco SchiumaInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Alice CovizziInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Matteo SianoInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Cinzia BassoliInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Matteo PasseriniInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Marco PiscagliaInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Alessandro TorreInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy.
Letizia OreniInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy.
Giuliano RizzardiniInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy.
Massimo GalliInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Anna Lisa RidolfoInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy.
Spinello AntinoriInfectious Diseases Department, ASST Fatebenefratelli-Sacco, Milan, Italy; Department of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, ViralVaccinesBNT162 VaccineCOVID-19 VaccinesCross-Sectional StudiesHumansImmunoglobulin GAntibodies, ViralBNT162 VaccineCOVID-19 VaccinesImmunoglobulin GVaccines

Identifiers

PMID34062183
PMCPMC8164509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.